Goodwin Guides Freenome in Over $200 Million Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
December 03, 2025
December 03, 2025
BOSTON, Massachusetts, Dec. 3 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Guides Freenome in Over $200 Million Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
*
The Life Sciences team guided Freenome on a strategic collaboration agreement with Roche to commercialize Freenome's cancer screening techno . . .
* * *
Goodwin Guides Freenome in Over $200 Million Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
*
The Life Sciences team guided Freenome on a strategic collaboration agreement with Roche to commercialize Freenome's cancer screening techno . . .
